Immunomedics Extends Patent Life on Therapeutic AntibodiesWall Street JournalMORRIS PLAINS, N.J., Feb. 26, 2014 (GLOBE NEWSWIRE) — Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibod…
Immunomedics Extends Patent Life on Therapeutic Antibodies – MarketWatch
|
Immunomedics Extends Patent Life on Therapeutic Antibodies
MarketWatch 8,658,773, which protects a method of concentrating antibodies for subcutaneous, intramuscular or transdermal administration. The patent covers all of the Company’s therapeutic antibodies, and can also be applied to most other antibodies, permitting a … Immunomedics to Present at Cowen and Company 34th Annual Health Care …Virtual-Strategy Magazine (press release) |
Sisters junior eyes medical career – Bend Bulletin
|
Sisters junior eyes medical career
Bend Bulletin One of the speakers was a woman who’d been burned by acid and underwent a first-of-its-kind face transplant surgery. “It’s an amazing idea that you could do that for someone,” Maddi said. “That you could make that big of an impact on somebody. One of … |
Transplant drugs may cause body to reject new lungs – Futurity: Research News
GPB |
Transplant drugs may cause body to reject new lungs
Futurity: Research News Researchers found mice were more likely to reject newly transplanted lungs if key immune cells were missing, a situation that simulates what happens when patients take immunosuppressive drugs. These “memory T cells” are primed to “remember” … New clues found to preventing lung transplant rejectionWashington University in St. Louis News |
Prior resection poses certain risks in lung transplantation – The Oncology Report
|
Prior resection poses certain risks in lung transplantation
The Oncology Report ORLANDO – Prior lung resection is associated with increased early mortality and with a more than twofold increased risk of renal failure requiring dialysis in lung transplant recipients, data from the United Network for Organ Sharing suggest. Prior … |
CORDIS – THYMISTEM researches stem cell therapies for damaged immune … – DeHavilland (press release) (subscription)
CORDIS – THYMISTEM researches stem cell therapies for damaged immune …DeHavilland (press release) (subscription)The thymus plays a central role in the development of our immune system by producing important immune cells. However, this crucial organ d…
Organ donations from deceased donors up 17 per cent over past decade – Regina Leader-Post
|
Organ donations from deceased donors up 17 per cent over past decade
Regina Leader-Post Organ donations from deceased donors up 17 per cent over past decade … Still, the total number of deceased donors in the country in 2012 was 540 people — a small number given the large need for donated organs. While there … In order to be an organ … |
The definitions and dilemmas of brain death – Medical Xpress
|
The definitions and dilemmas of brain death
Medical Xpress The definitions—and dilemmas—of brain death go back at least as far as 1968 and an Ad Hoc Committee to Examine the Definition of Brain Death, she says. At the time, there were two complications: if someone ended up in intensive care, they could be … |
Idelalisib Shows Promising Activity in Heavily Pretreated iNHL – OncLive
Idelalisib Shows Promising Activity in Heavily Pretreated iNHLOncLiveThe majority of patients (89%) had stage III or IV disease and all patients had not responded favorably to rituximab and an alkylating agent or had relapsed within 6 months of treatme…
Sisters High junior has a mind for medicine – Bend Bulletin
|
Sisters High junior has a mind for medicine
Bend Bulletin One of the speakers was a woman who’d been burned by acid and underwent a first-of-its-kind face transplant surgery. “It’s an amazing idea that you could do that for someone,” Maddi said. “That you could make that big of an impact on somebody. One of … |